Myeloid-derived suppressor cells: their role in the pathophysiology of hematologic malignancies and potential as therapeutic targets (Q38269370)

1 September 2017

1 reference

title

Myeloid-derived suppressor cells: their role in the pathophysiology of hematologic malignancies and potential as therapeutic targets (English)

1 reference

1 September 2017

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25407654%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

author name string

Fuminori Abe

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25407654%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

James E Talmadge

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25407654%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

publication date

19 November 2014

1 reference

1 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25407654%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

volume

56

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25407654%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25407654%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

page(s)

2251-2263

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25407654%20AND%20SRC:MED&resulttype=core&format=json

Pathways mediating the expansion and immunosuppressive activity of myeloid-derived suppressor cells and their relevance to cancer therapy

9 June 2020

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Mechanisms of immune evasion by tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

History of myeloid-derived suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Myeloid-derived suppressor cells: the dark knight or the joker in viral infections?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Myeloid-derived suppressor cells--their role in haemato-oncological malignancies and other cancers and possible implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Mammary tumor heterogeneity in the expansion of myeloid-derived suppressor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Myeloid cells in the tumor microenvironment: modulation of tumor angiogenesis and tumor inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Myeloid-derived suppressor cells function as novel osteoclast progenitors enhancing bone loss in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Myeloid-derived suppressor cells in mammary tumor progression in FVB Neu transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Tricks tumors use to escape from immune control

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Myeloid-derived suppressor cells in cancer patients: a clinical perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

On the armament and appearances of human myeloid-derived suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Resection of the primary tumor improves survival in metastatic breast cancer by reducing overall tumor burden.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Cytoreduction surgery reduces systemic myeloid suppressor cell populations and restores intratumoral immunotherapy effectiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Myeloid suppressor lines inhibit T cell responses by an NO-dependent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Neutrophils and granulocytic myeloid-derived suppressor cells: immunophenotyping, cell biology and clinical relevance in human oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Reversal of myeloid cell-mediated immunosuppression in patients with metastatic renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Mechanism of all-trans retinoic acid effect on tumor-associated myeloid-derived suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

The restoration of myeloid‐derived suppressor cells as functional antigen‐presenting cells by NKT cell help and all‐trans‐retinoic acid treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Therapeutic regulation of myeloid-derived suppressor cells and immune response to cancer vaccine in patients with extensive stage small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

1alpha,25-Dihydroxyvitamin D(3) to skew intratumoral levels of immune inhibitory CD34(+) progenitor cells into dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Use of alpha,25-dihydroxyvitamin D3 treatment to stimulate immune infiltration into head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Immunological modulation by 1α,25-dihydroxyvitamin D3 in patients with squamous cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Gemcitabine directly inhibits myeloid derived suppressor cells in BALB/c mice bearing 4T1 mammary carcinoma and augments expansion of T cells from tumor-bearing mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

5-Fluorouracil selectively kills tumor-associated myeloid-derived suppressor cells resulting in enhanced T cell-dependent antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Enhanced antitumoral activity of oncolytic herpes simplex virus with gemcitabine using colorectal tumor models

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

The effects of gemcitabine and capecitabine combination chemotherapy and of low-dose adjuvant GM-CSF on the levels of myeloid-derived suppressor cells in patients with advanced pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Phase 2 study of neoadjuvant treatment with NOV-002 in combination with doxorubicin and cyclophosphamide followed by docetaxel in patients with HER-2 negative clinical stage II–IIIc breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Sunitinib inhibition of Stat3 induces renal cell carcinoma tumor cell apoptosis and reduces immunosuppressive cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Sunitinib mediates reversal of myeloid-derived suppressor cell accumulation in renal cell carcinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Reversion of immune tolerance in advanced malignancy: modulation of myeloid-derived suppressor cell development by blockade of stem-cell factor function

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

The novel role of tyrosine kinase inhibitor in the reversal of immune suppression and modulation of tumor microenvironment for immune-based cancer therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Sunitinib facilitates the activation and recruitment of therapeutic anti‐tumor immunity in concert with specific vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Vaccination of Metastatic Renal Cancer Patients with MVA-5T4: A Randomized, Double-Blind, Placebo-Controlled Phase III Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Consequence of dose scheduling of sunitinib on host immune response elements and vaccine combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Oxidative stress regulates expression of VEGFR1 in myeloid cells: link to tumor-induced immune suppression in renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Vemurafenib reverses immunosuppression by myeloid derived suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

The BRAF-MAPK signaling pathway is essential for cancer-immune evasion in human melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

CSF1R signaling blockade stanches tumor-infiltrating myeloid cells and improves the efficacy of radiotherapy in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Targeting distinct tumor-infiltrating myeloid cells by inhibiting CSF-1 receptor: combating tumor evasion of antiangiogenic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Inhibition of CSF-1 receptor improves the antitumor efficacy of adoptive cell transfer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Stat3 mediates myeloid cell-dependent tumor angiogenesis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Activation of dendritic cells via inhibition of Jak2/STAT3 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Bisphosphonates: mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Amino-biphosphonate-mediated MMP-9 inhibition breaks the tumor-bone marrow axis responsible for myeloid-derived suppressor cell expansion and macrophage infiltration in tumor stroma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Pancreatic adenocarcinoma induces bone marrow mobilization of myeloid-derived suppressor cells which promote primary tumor growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Targeting immune suppression with PDE5 inhibition in end-stage multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Nitroaspirin corrects immune dysfunction in tumor-bearing hosts and promotes tumor eradication by cancer vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Myeloid-derived suppressor cell inhibition of the IFN response in tumor-bearing mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Chemokine nitration prevents intratumoral infiltration of antigen-specific T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Preclinical evaluation of targeting the Nrf2 pathway by triterpenoids (CDDO-Im and CDDO-Me) for protection from LPS-induced inflammatory response and reactive oxygen species in human peripheral blood mononuclear cells and neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Dihydro-CDDO-trifluoroethyl amide suppresses inflammatory responses in macrophages via activation of Nrf2

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

The novel triterpenoid C-28 methyl ester of 2-cyano-3, 12-dioxoolen-1, 9-dien-28-oic acid inhibits metastatic murine breast tumor growth through inactivation of STAT3 signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Preclinical evidences toward the use of triterpenoid CDDO-Me for solid cancer prevention and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Anti-inflammatory triterpenoid blocks immune suppressive function of MDSCs and improves immune response in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

COX-2 inhibition improves immunotherapy and is associated with decreased numbers of myeloid-derived suppressor cells in mesothelioma. Celecoxib influences MDSC function

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Clinical significance of B7-H1 (PD-L1) expression in human acute leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Allogeneic hematopoietic cell transplantation for adults with acute myeloid leukemia: myths, controversies, and unknowns

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

CLL-cells induce IDOhi CD14+HLA-DRlo myeloid-derived suppressor cells that inhibit T-cell responses and promote TRegs.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

CD40 ligation reverses T cell tolerance in acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Acute myeloid leukemia creates an arginase-dependent immunosuppressive microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Increased level of myeloid-derived suppressor cells, programmed death receptor ligand 1/programmed death receptor 1, and soluble CD25 in Sokal high risk chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Induction of myelodysplasia by myeloid-derived suppressor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Correlation between IL-3 receptor expression and growth potential of human CD34+ hematopoietic cells from different tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Human peripheral blood contains two distinct lineages of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Interleukin-3 receptor in acute leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

CD 123 is a membrane biomarker and a therapeutic target in hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Monoclonal antibody-mediated targeting of CD123, IL-3 receptor alpha chain, eliminates human acute myeloid leukemic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Internal tandem duplication of FLT3 (FLT3/ITD) induces increased ROS production, DNA damage, and misrepair: implications for poor prognosis in AML.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

G-CSF induced reactive oxygen species involves Lyn-PI3-kinase-Akt and contributes to myeloid cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Induction of apoptosis in a human leukemic cell line via reactive oxygen species modulation by antioxidants

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Involvement of oxidative stress in the relapse of acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Novel roles of reactive oxygen species in the pathogenesis of acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Cutting edge: Flt3 ligand mediates STAT3-independent expansion but STAT3-dependent activation of myeloid-derived suppressor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Mini ReviewFLT3: Receptor and Ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

21 January 2018

Role of FLT3 in leukemia

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Mechanism of immune dysfunction in cancer mediated by immature Gr-1+ myeloid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Dendritic cells are defective in breast cancer patients: a potential role for polyamine in this immunodeficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Cellular mechanisms of multiple myeloma bone disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Tumour immunogenicity, antigen presentation and immunological barriers in cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Myeloid-derived suppressor cells regulate growth of multiple myeloma by inhibiting T cells in bone marrow.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Tumor-promoting immune-suppressive myeloid-derived suppressor cells in the multiple myeloma microenvironment in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Myeloid derived suppressor cells are numerically, functionally and phenotypically different in patients with multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Myeloma plasma cells alter the bone marrow microenvironment by stimulating the proliferation of mesenchymal stromal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Myeloid-derived suppressor cells as osteoclast progenitors: a novel target for controlling osteolytic bone metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Myeloid-derived suppressor cells expand during breast cancer progression and promote tumor-induced bone destruction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Osteoclasts in multiple myeloma are derived from Gr-1+CD11b+myeloid-derived suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Inflammatory arthritis increases mouse osteoclast precursors with myeloid suppressor function

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Late relapses following reduced intensity allogeneic transplantation in patients with multiple myeloma: a long-term follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Trial Watch: Lenalidomide-based immunochemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

MicroRNA-155 and MicroRNA-21 promote the expansion of functional myeloid-derived suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Absolute monocyte/lymphocyte count prognostic score is independent of immunohistochemically determined cell of origin in predicting survival in diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

The absolute monocyte and lymphocyte prognostic score predicts survival and identifies high-risk patients in diffuse large-B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

The absolute monocyte count is associated with overall survival in patients newly diagnosed with follicular lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Immunosuppressive CD14+HLA-DR(low)/- monocytes in B-cell non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in nodular lymphocyte‐predominantHodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Impact of visceral involvements and blood cell count abnormalities on survival in adult T-cell leukemia/lymphoma (ATLL).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

The aggressive peripheral T‐cell lymphomas: 2012 update on diagnosis, risk stratification, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Monocytes promote tumor cell survival in T-cell lymphoproliferative disorders and are impaired in their ability to differentiate into mature dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

High numbers of tumor-associated macrophages have an adverse prognostic value that can be circumvented by rituximab in patients with follicular lymphoma enrolled onto the GELA-GOELAMS FL-2000 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Angiogenesis extent and macrophage density increase simultaneously with pathological progression in B-cell non-Hodgkin's lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Phase 1B study to improve immune responses in head and neck cancer patients using escalating doses of 25-hydroxyvitamin D3.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Sunitinib reverses type-1 immune suppression and decreases T-regulatory cells in renal cell carcinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

PGE(2)-induced CXCL12 production and CXCR4 expression controls the accumulation of human MDSCs in ovarian cancer environment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Myeloid derived suppressor cells - a new therapeutic target in the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

Prediction of Survival in Follicular Lymphoma Based on Molecular Features of Tumor-Infiltrating Immune Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.987141

10.3109/10428194.2014.987141

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25407654%20AND%20SRC:MED&resulttype=core&format=json

release_vwoomrdzljg5nhakgyanox5bmq

9 June 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/vwoomrdzljg5nhakgyanox5bmq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25407654%20AND%20SRC:MED&resulttype=core&format=json